298 related articles for article (PubMed ID: 17764690)
21. Cdc37 goes beyond Hsp90 and kinases.
MacLean M; Picard D
Cell Stress Chaperones; 2003; 8(2):114-9. PubMed ID: 14627196
[TBL] [Abstract][Full Text] [Related]
22. Modulation of chaperone function and cochaperone interaction by novobiocin in the C-terminal domain of Hsp90: evidence that coumarin antibiotics disrupt Hsp90 dimerization.
Allan RK; Mok D; Ward BK; Ratajczak T
J Biol Chem; 2006 Mar; 281(11):7161-71. PubMed ID: 16421106
[TBL] [Abstract][Full Text] [Related]
23. The human Cdc37.Hsp90 complex studied by heteronuclear NMR spectroscopy.
Sreeramulu S; Jonker HR; Langer T; Richter C; Lancaster CR; Schwalbe H
J Biol Chem; 2009 Feb; 284(6):3885-96. PubMed ID: 19073599
[TBL] [Abstract][Full Text] [Related]
24. The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones.
Li J; Soroka J; Buchner J
Biochim Biophys Acta; 2012 Mar; 1823(3):624-35. PubMed ID: 21951723
[TBL] [Abstract][Full Text] [Related]
25. Integration of the accelerator Aha1 in the Hsp90 co-chaperone cycle.
Li J; Richter K; Reinstein J; Buchner J
Nat Struct Mol Biol; 2013 Mar; 20(3):326-31. PubMed ID: 23396352
[TBL] [Abstract][Full Text] [Related]
26. A primate specific extra domain in the molecular chaperone Hsp90.
Tripathi V; Obermann WM
PLoS One; 2013; 8(8):e71856. PubMed ID: 23951259
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylated and unphosphorylated serine 13 of CDC37 stabilize distinct interactions between its client and HSP90 binding domains.
Liu W; Landgraf R
Biochemistry; 2015 Feb; 54(7):1493-504. PubMed ID: 25619116
[TBL] [Abstract][Full Text] [Related]
28. Structural studies on the co-chaperone Hop and its complexes with Hsp90.
Onuoha SC; Coulstock ET; Grossmann JG; Jackson SE
J Mol Biol; 2008 Jun; 379(4):732-44. PubMed ID: 18485364
[TBL] [Abstract][Full Text] [Related]
29. Middle domain of human Hsp90 isoforms differentially binds Aha1 in human cells and alters Hsp90 activity in yeast.
Synoradzki K; Bieganowski P
Biochim Biophys Acta; 2015 Feb; 1853(2):445-52. PubMed ID: 25486457
[TBL] [Abstract][Full Text] [Related]
30. Chemical Perturbation of Oncogenic Protein Folding: from the Prediction of Locally Unstable Structures to the Design of Disruptors of Hsp90-Client Interactions.
Paladino A; Woodford MR; Backe SJ; Sager RA; Kancherla P; Daneshvar MA; Chen VZ; Bourboulia D; Ahanin EF; Prodromou C; Bergamaschi G; Strada A; Cretich M; Gori A; Veronesi M; Bandiera T; Vanna R; Bratslavsky G; Serapian SA; Mollapour M; Colombo G
Chemistry; 2020 Aug; 26(43):9459-9465. PubMed ID: 32167602
[TBL] [Abstract][Full Text] [Related]
31. Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37.
Nony P; Gaude H; Rossel M; Fournier L; Rouault JP; Billaud M
Oncogene; 2003 Dec; 22(57):9165-75. PubMed ID: 14668798
[TBL] [Abstract][Full Text] [Related]
32. Threonine 22 phosphorylation attenuates Hsp90 interaction with cochaperones and affects its chaperone activity.
Mollapour M; Tsutsumi S; Truman AW; Xu W; Vaughan CK; Beebe K; Konstantinova A; Vourganti S; Panaretou B; Piper PW; Trepel JB; Prodromou C; Pearl LH; Neckers L
Mol Cell; 2011 Mar; 41(6):672-81. PubMed ID: 21419342
[TBL] [Abstract][Full Text] [Related]
33. Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones.
Prodromou C; Siligardi G; O'Brien R; Woolfson DN; Regan L; Panaretou B; Ladbury JE; Piper PW; Pearl LH
EMBO J; 1999 Feb; 18(3):754-62. PubMed ID: 9927435
[TBL] [Abstract][Full Text] [Related]
34. Discovery of a covalent inhibitor of heat shock protein 90 with antitumor activity that blocks the co-chaperone binding via C-terminal modification.
Li L; Chen N; Xia D; Xu S; Dai W; Tong Y; Wang L; Jiang Z; You Q; Xu X
Cell Chem Biol; 2021 Oct; 28(10):1446-1459.e6. PubMed ID: 33932325
[TBL] [Abstract][Full Text] [Related]
35. 1H, 13C and 15N backbone resonance assignment of the Hsp90 binding domain of human Cdc37.
Sreeramulu S; Kumar J; Richter C; Vogtherr M; Saxena K; Langer T; Schwalbe H
J Biomol NMR; 2005 Jul; 32(3):262. PubMed ID: 16132836
[No Abstract] [Full Text] [Related]
36. Stability of the human Hsp90-p50Cdc37 chaperone complex against nucleotides and Hsp90 inhibitors, and the influence of phosphorylation by casein kinase 2.
Olesen SH; Ingles DJ; Zhu JY; Martin MP; Betzi S; Georg GI; Tash JS; Schönbrunn E
Molecules; 2015 Jan; 20(1):1643-60. PubMed ID: 25608045
[TBL] [Abstract][Full Text] [Related]
37. Functional specificity of co-chaperone interactions with Hsp90 client proteins.
Riggs DL; Cox MB; Cheung-Flynn J; Prapapanich V; Carrigan PE; Smith DF
Crit Rev Biochem Mol Biol; 2004; 39(5-6):279-95. PubMed ID: 15763706
[TBL] [Abstract][Full Text] [Related]
38. Definition of protein kinase sequence motifs that trigger high affinity binding of Hsp90 and Cdc37.
Prince T; Matts RL
J Biol Chem; 2004 Sep; 279(38):39975-81. PubMed ID: 15258137
[TBL] [Abstract][Full Text] [Related]
39. Cdc37 as a Co-chaperone to Hsp90.
Prince TL; Lang BJ; Okusha Y; Eguchi T; Calderwood SK
Subcell Biochem; 2023; 101():141-158. PubMed ID: 36520306
[TBL] [Abstract][Full Text] [Related]
40. A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.
Stiegler SC; Rübbelke M; Korotkov VS; Weiwad M; John C; Fischer G; Sieber SA; Sattler M; Buchner J
J Biol Chem; 2017 Oct; 292(41):17073-17083. PubMed ID: 28851842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]